Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
about
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.Covalent Organic Frameworks: From Materials Design to Biomedical Application.Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective.SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
P2860
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@en
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@nl
type
label
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@en
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@nl
prefLabel
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@en
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery.
@nl
P2093
P2860
P356
P1433
P1476
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
@en
P2093
Domenico Lombardo
Mikhail A Kiselev
Pietro Calandra
Salvatore Magazù
P2860
P356
10.3390/NANO6070125
P577
2016-06-25T00:00:00Z